×
About 154 results

ALLMedicine™ Activated Protein C Resistance Center

Research & Reviews  77 results

Insight into the hypercoagulable state of high-risk thrombotic APS patients: Contributi...
https://doi.org/10.1111/jth.15199
Journal of Thrombosis and Haemostasis : JTH; Pontara E, Cattini MG et. al.

Nov 29th, 2020 - Most high-risk thrombotic antiphospholipid syndrome (APS) patients test positive for anti-β2-glycoprotein I (aβ2GPI) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies. Information on the influence of these antibodies on thrombin generati...

Laboratory testing for activated protein C resistance: rivaroxaban induced interference...
https://doi.org/10.1515/cclm-2019-1160
Clinical Chemistry and Laboratory Medicine; Favaloro EJ, Gilmore G et. al.

Mar 3rd, 2020 - Background Investigation of hemostasis is problematic when patients are on anticoagulant therapy. Rivaroxaban especially causes substantial interference, extending many clot-based tests, thereby leading to false positive or negative events. In par...

Apixaban Does Not Interfere With Protein S or Activated Protein C Resistance (Factor V ...
https://doi.org/10.5858/arpa.2019-0497-OA
Archives of Pathology & Laboratory Medicine; Maryamchik E, Van Cott EM

Feb 26th, 2020 - Apixaban causes a false increase in activated protein C resistance (APCR) ratios and possibly protein S activity. To investigate whether this increase can mask a diagnosis of factor V Leiden (FVL) or protein S deficiency in an actual population of...

Proof of concept of a new scale for the harmonization and the standardization of the ET...
https://doi.org/10.1111/jth.14745
Journal of Thrombosis and Haemostasis : JTH REFERENCES; Morimont L, Bouvy C et. al.

Jan 27th, 2020 - The evaluation of the activated protein C resistance (APCr) based on the endogenous thrombin potential (ETP) is recommended during the development of steroid contraceptives. Results are usually expressed as "normalized APC sensitivity ratio" (nAPC...

DOAC-Remove abolishes the effect of direct oral anticoagulants on activated protein C r...
https://doi.org/10.1515/cclm-2019-0650
Clinical Chemistry and Laboratory Medicine; Kopytek M, Ząbczyk M et. al.

Sep 20th, 2019 - Background Direct oral anticoagulants (DOACs) may cause false results of activated protein C resistance (APC-R) ratio. DOAC-Remove, a new reagent based on activated carbon, has been designed to eliminate the interference of DOACs on coagulation as...

see more →

Clinicaltrials.gov  77 results

Insight into the hypercoagulable state of high-risk thrombotic APS patients: Contributi...
https://doi.org/10.1111/jth.15199
Journal of Thrombosis and Haemostasis : JTH; Pontara E, Cattini MG et. al.

Nov 29th, 2020 - Most high-risk thrombotic antiphospholipid syndrome (APS) patients test positive for anti-β2-glycoprotein I (aβ2GPI) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies. Information on the influence of these antibodies on thrombin generati...

Laboratory testing for activated protein C resistance: rivaroxaban induced interference...
https://doi.org/10.1515/cclm-2019-1160
Clinical Chemistry and Laboratory Medicine; Favaloro EJ, Gilmore G et. al.

Mar 3rd, 2020 - Background Investigation of hemostasis is problematic when patients are on anticoagulant therapy. Rivaroxaban especially causes substantial interference, extending many clot-based tests, thereby leading to false positive or negative events. In par...

Apixaban Does Not Interfere With Protein S or Activated Protein C Resistance (Factor V ...
https://doi.org/10.5858/arpa.2019-0497-OA
Archives of Pathology & Laboratory Medicine; Maryamchik E, Van Cott EM

Feb 26th, 2020 - Apixaban causes a false increase in activated protein C resistance (APCR) ratios and possibly protein S activity. To investigate whether this increase can mask a diagnosis of factor V Leiden (FVL) or protein S deficiency in an actual population of...

Proof of concept of a new scale for the harmonization and the standardization of the ET...
https://doi.org/10.1111/jth.14745
Journal of Thrombosis and Haemostasis : JTH REFERENCES; Morimont L, Bouvy C et. al.

Jan 27th, 2020 - The evaluation of the activated protein C resistance (APCr) based on the endogenous thrombin potential (ETP) is recommended during the development of steroid contraceptives. Results are usually expressed as "normalized APC sensitivity ratio" (nAPC...

DOAC-Remove abolishes the effect of direct oral anticoagulants on activated protein C r...
https://doi.org/10.1515/cclm-2019-0650
Clinical Chemistry and Laboratory Medicine; Kopytek M, Ząbczyk M et. al.

Sep 20th, 2019 - Background Direct oral anticoagulants (DOACs) may cause false results of activated protein C resistance (APC-R) ratio. DOAC-Remove, a new reagent based on activated carbon, has been designed to eliminate the interference of DOACs on coagulation as...

see more →